Polycystic ovary syndrome - "A riddle wrapped in a mystery inside an enigma"

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 6, 2009, Pages 1883-1885

  Padmanabhan, Vasantha ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; INSULIN; LUTEINIZING HORMONE; STEROID 21 MONOOXYGENASE; TESTOSTERONE;

ANDROGEN SYNTHESIS; ANOVULATION; CHROMOSOME 19P; DISEASE ASSOCIATION; DIZYGOTIC TWINS; EDITORIAL; ENVIRONMENTAL FACTOR; FEMALE; GENE INTERACTION; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HERITABILITY; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; HYPERINSULINISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; LUTEINIZING HORMONE RELEASE; METABOLIC DISORDER; MONOZYGOTIC TWINS; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROGENY; PUBERTY; SEXUAL MATURATION; STEROID 21 MONOOXYGENASE DEFICIENCY; STEROIDOGENESIS;

EID: 66749128492     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0492     Document Type: Editorial

References (20)

1. Boomsma CM, Fauser BC, Macklon NS 2008 Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med 26:72-84
2. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800 (Pubitemid 28009567)
3. Essah PA, Nestler JE 2006 The metabolic syndrome in polycystic ovary syndrome. J Endocrinol Invest 29:270-280 (Pubitemid 43913779)
4. Hart R, Norman R 2006 Polycystic ovarian syndrome-prognosis and outcomes. Best Pract Res Clin Obstet Gynaecol 2006 20:751-778
5. Junien C, Gallou-Kabani C, Vigé A, Gross MS 2005 Nutritional epigenomics of metabolic syndrome. Med Sci (Paris) 21:396-404 (Pubitemid 40544071)
6. Sir-Petermann T, Codner E, Pérez V, Echiburú B, Maliqueo M, de Guevara AL, Preisler J, Crisosto N, Sánchez F, Cassorla F, Bhasin S 2009 Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 94:1923-1930
7. Franks S, McCarthy MI, Hardy K 2006 Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int J Androl 29:278-285; discussion 286-290
8. Stewart DR, Dombroski BA, Urbanek M, Ankener W, Ewens KG, Wood JR, Legro RS, Strauss 3rd JF, Dunaif A, Spielman RS 2006 Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity. J Clin Endocrinol Metab 91:4112-4117
9. Legro RS, Driscoll D, Strauss 3rd JF, Fox J, Dunaif A 1998 Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 95:14956-14960 (Pubitemid 29003738)
10. Yildiz BO, Yarali H, Oguz H, Bayraktar M 2003 Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:2031-2036 (Pubitemid 36549872)
11. Vink JM, Sadrzadeh S, Lambalk CB, Boomsma DI 2006 Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab 91:2100-2104
12. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF; Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society 2009 The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91:456-488
13. Kent SC, Gnatuk CL, Kunselman AR, Demers LM, Lee PA, Legro RS 2008 Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab 93:1662-1669
14. Barker DJP 1994 Programming the baby. Mothers, babies, and disease in later life. London: BMJ Publishing Group; 14-36
15. Barnes RB, Rosenfield RL, Ehrmann DA, Cara JF, Cuttler L, Levitsky LL, Rosenthal IM 1994 Ovarian hyperandrogenism as a result of congenital adrenal virilizing disorders: evidence for prenatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab 79:1328-1333 (Pubitemid 24369843)
16. Abbott DH, Dumesic DA, Levine JE, Dunaif A, Padmanabhan V 2006 Animal models and fetal programming of PCOS. In: Azziz R, Nestler JE, and Dewailly D, eds. Contemporary endocrinology: androgen excess disorders in women - polycystic ovary syndrome and other disorders. 2nd ed. Totowa, NJ: Humana Press Inc.; 259-272
17. Rosenfield RL 2007 Clinical review: identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 92:787-796 (Pubitemid 46465641)
18. Blank SK, Helm KD, McCartney CR, Marshall JC 2008 Polycystic ovary syndrome in adolescence. Ann NY Acad Sci 1135:76-84
19. Tang WY, Newbold R, Mardilovich K, Jefferson W, Cheng RY, Medvedovic M, Ho SM 2008 Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein. Endocrinology 149:5922-5931
20. Steckler TL, Herkimer C, Dumesic DA, Padmanabhan V 2009 Developmental programming: excess weight gain amplifies the effects of prenatal testosterone excess on reproductive cyclicity - implication to PCOS. Endocrinology 150:1456-1465